Clinical Trial Update: A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing saxagliptin with dapagliflozin plus metformin versus glimepiride with metformin in type 2 diabetes with inadequate glycemic control; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Glimepiride (glimepiride)
• Saxagliptin (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2018-10-19